<div id="readability-page-1"><div> By Megan Cheah <pre></pre> Wuxi AppTec plans to raise around $1 billion by issuing U.S. dollar-settled zero coupon convertible bonds, as it seeks to boost its capacity and capabilities. The Shanghai-based company, which provides drug research, development and manufacturing services, plans to issue the bonds with a principal amount of 6.78 billion yuan, equivalent to $999 million, Wuxi AppTec said Friday. The bonds can be converted to Hong Kong-listed shares at an initial conversion price of 153 Hong Kong dollars per share, or $19.54, subject to adjustments and conditions, said the company, which is listed in both Shanghai and Hong Kong. The conversion price is a premium of around 18% over Wuxi AppTec's Thursday closing price of HK$130.10, the company said. Assuming full conversion of all the bonds at this price, the converted shares will represent around 9.1% of Wuxi's enlarged H-share capital and around 1.7% of its total issued share capital. Wuxi intends to use the net proceeds of around $1.02 billion for global capacity and capability expansion, and general corporate purposes. Morgan Stanley, Citigroup and Goldman Sachs are the banks advising Wuxi on its bond issuance. Wuxi AppTec's shares in Hong Kong closed 5.2% lower at HK$130.10 on Thursday, but are about 32% higher year to date. <pre></pre> Write to Megan Cheah at megan.cheah@wsj.com <pre></pre> (END) Dow Jones Newswires May 14, 2026 20:41 ET (00:41 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

藥明康德

華夏恆生生物科技ETF(QDII)

易方達滬深300醫藥ETF

藥明康德計劃通過以美元結算的零息可轉換債券籌集約 10 億美元，以增強其產能和能力。這些債券可按初始價格 HK$153 轉換為股份，約佔擴大後 H 股資本的 9.1%。籌集的資金將用於全球擴展和公司用途。摩根士丹利、花旗集團和高盛正在為此次發行提供諮詢

Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds

MorningStar

華寶恆生港股通創新藥精選ETF

匯添富國證港股通創新藥ETF

易方達中證生物科技主題ETF

華夏中證生物科技主題ETF

華寶中證制藥ETF

生物科技ETF基金

國泰中證生物醫藥ETF

華泰柏瑞恆生創新藥ETF(QDII)

摩根士丹利

花旗

高盛

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

藥明康德計劃通過發行零息可轉換債券籌集約 10 億美元